Tag Archives: Patrick Mahaffy

The President & CEO of Clovis Oncology (NASDAQ: CLVS) is Buying Shares

Today, the President & CEO of Clovis Oncology (CLVS – Research Report), Patrick Mahaffy, bought shares of CLVS for $279.6K. Following this transaction Patrick Mahaffy’s holding in the company was increased by 5.74% to a total of $5.18 million. In